The economic burden of severe asthma in children: a comprehensive study

References

• WHO. Fact sheet on asthma: WHO. Available from: http://www.who.int/en/news-room/fact-sheets/detail/asthma [updated 31 August 2017].
   Google Scholar
• Delmas M-C, Guignon N, Leynaert B, Moisy M, Marguet C, Fuhrman C. Augmentation de la prévalence de l’asthme chez le jeune enfant en France. Rev Mal Respir. 2017;34(5):525–534. doi:https://doi.org/10.1016/j.rmr.2016.09.002.
   PubMedGoogle Scholar
• Delmas MC, Guignon N, Leynaert B, Com Ruelle L, Annesi Maesano I, Chardon O, Fuhrman C. Trends in asthma prevalence in children in France: data from the national health surveys among schoolchildren, 2003-2008. Bull Epidémiologique Hebd. 2014;(20):360–365.
   Google Scholar
• Fleming L, Heaney L. Severe asthma-perspectives from adult and pediatric pulmonology. Front Pediatr. 2019;7:389. doi:https://doi.org/10.3389/fped.2019.00389.
   PubMed Web of Science ®Google Scholar
• Weinmann S, Kamtsiuris P, Henke K-D, Wickman M, Jenner A, Wahn U. The costs of atopy and asthma in children: Assessment of direct costs and their determinants in a birth cohort. Pediatr Allergy Immunol. 2003;14(1):18–26. doi:https://doi.org/10.1034/j.1399-3038.2003.02085.x.
   PubMed Web of Science ®Google Scholar
• Szefler SJ, Zeiger RS, Haselkorn T, Mink DR, Kamath TV, Fish JE, Chipps BE. Economic burden of impairment in children with severe or difficult-to-treat asthma. Ann Allergy Asthma Immunol. 2011;107(2):110–119.e1. doi:https://doi.org/10.1016/j.anai.2011.04.008.
   PubMed Web of Science ®Google Scholar
• Schramm B, Ehlken B, Smala A, Quednau K, Berger K, Nowak D. Cost of illness of atopic asthma and seasonal allergic rhinitis in Germany: 1-yr retrospective study. Eur Respir J. 2003;21(1):116–122. doi:https://doi.org/10.1183/09031936.03.00019502.
   PubMed Web of Science ®Google Scholar
• Blasco Bravo AJ, Pérez-Yarza EG, de Mercado P. y, Perales AB, Díaz Vazquez CA, Moreno Galdó A. Coste del asma en pediatría en España: un modelo de evaluación de costes basado en la prevalencia. An Pediatr. 2011;74(3):145–153. doi:https://doi.org/10.1016/j.anpedi.2010.10.006.
   Google Scholar
• Fleming L, Murray C, Bansal AT, Hashimoto S, Bisgaard H, Bush A, Frey U, Hedlin G, Singer F, van Aalderen WM, et al. The burden of severe asthma in childhood and adolescence: results from the paediatric U-BIOPRED cohorts. Eur Respir J. 2015;46(5):1322–1333. doi:https://doi.org/10.1183/13993003.00780-2015.
   PubMed Web of Science ®Google Scholar
• Chastek B, Korrer S, Nagar SP, Albers F, Yancey S, Ortega H, Forshag M, Dalal AA. Economic burden of illness among patients with severe asthma in a managed care setting. JMCP. 2016;22(7):848–861. doi:https://doi.org/10.18553/jmcp.2016.22.7.848.
   PubMedGoogle Scholar
• Kim C-Y, Park H-W, Ko S-K, Chang S-I, Moon H-B, Kim Y-Y, Cho S-H. The financial burden of asthma: a nationwide comprehensive survey conducted in the Republic of Korea. Allergy Asthma Immunol Res. 2011;3(1):34–38. doi:https://doi.org/10.4168/aair.2011.3.1.34.
   PubMed Web of Science ®Google Scholar
• Colice G, Wu EQ, Birnbaum H, Daher M, Marynchenko MB, Varghese S. Healthcare and workloss costs associated with patients with persistent asthma in a privately insured population. J Occup Environ Med. 2006;48(8):794–802.
   PubMed Web of Science ®Google Scholar
• Sadatsafavi M, Lynd L, Marra C, Carleton B, Tan WC, Sullivan S, FitzGerald JM. Direct health care costs associated with asthma in British Columbia. Can Respir J. 2010;17(2):74–80. doi:https://doi.org/10.1155/2010/361071.
   PubMed Web of Science ®Google Scholar
• Costa E, Caetano R, Werneck GL, Bregman M, Araújo DV, Rufino R. Estimativa de custo da asma em tratamento ambulatorial: estudo com dados de mundo real. Rev Saúde Pública. 2018;52:27. doi:https://doi.org/10.11606/S1518-8787.2018052000153.
   PubMedGoogle Scholar
• Beyhun NE, Soyer ÖU, Kuyucu S, Sapan N, Altıntaş DU, Yüksel H, Anlar FY, Orhan F, Cevit Ö, Çokuğras H, et al. A multi-center survey of childhood asthma in Turkey - I: The cost and its determinants. Pediatr Allergy Immunol. 2009;20(1):72–80. doi:https://doi.org/10.1111/j.1399-3038.2008.00739.x.
   PubMed Web of Science ®Google Scholar
• Doz M, Chouaid C, Com-Ruelle L, Calvo E, Brosa M, Robert J, Decuypère L, Pribil C, Huerta A, Detournay B, et al. The association between asthma control, health care costs, and quality of life in France and Spain. BMC Pulm Med. 2013;13(1):15. doi:https://doi.org/10.1186/1471-2466-13-15.
   PubMed Web of Science ®Google Scholar
• Nordon C, Grimaldi-Bensouda L, Pribil C, Nachbaur G, Amzal B, Thabut G, Marthan R, Aubier M, COBRA Study Group Clinical and economic burden of severe asthma: A French cohort study. Respir Med. 2018;144:42–49. doi:https://doi.org/10.1016/j.rmed.2018.10.002.
   PubMed Web of Science ®Google Scholar
• Bourdin A, Fabry-Vendrand C, Ostinelli J, Ait-Yahia M, Darnal E, Bouee S, Laurendeau C, Bureau I, Gourmelen J, Chouaid C, et al. The burden of severe asthma in France: a case-control study using a medical claims database. J Allergy Clin Immunol Pract. 2019;7(5):1477–1487. doi:https://doi.org/10.1016/j.jaip.2018.12.029.
   PubMed Web of Science ®Google Scholar
• Sharples J, Gupta A, Fleming L, Bossley CJ, Bracken-King M, Hall P, Hayward A, Puckey M, Balfour-Lynn IM, Rosenthal M, et al. Long-term effectiveness of a staged assessment for paediatric problematic severe asthma. Eur Respir J. 2012;40(1):264–267. doi:https://doi.org/10.1183/09031936.00209511.
   PubMed Web of Science ®Google Scholar
• Nagakumar P, Puttur F, Gregory LG, Denney L, Fleming L, Bush A, Lloyd CM, Saglani S. Pulmonary type-2 innate lymphoid cells in paediatric severe asthma: phenotype and response to steroids. Eur Respir J. 2019;54(2):1801809. doi:https://doi.org/10.1183/13993003.01809-2018.
   PubMed Web of Science ®Google Scholar
• 2018 GINA Report, Global Strategy for Asthma Management and Prevention. 2018.
   Google Scholar
• Lezmi G, Abou-Taam R, Garcelon N, Dietrich C, Machavoine F, Delacourt C, Adel-Patient K, Leite-de-Moraes M. Evidence for a MAIT-17-high phenotype in children with severe asthma. J Allergy Clin Immunol. 2019;144(6):1714–1716.e6. doi:https://doi.org/10.1016/j.jaci.2019.08.003.
   PubMed Web of Science ®Google Scholar
• Lezmi G, Galmiche-Rolland L, Rioux S, Jaubert F, Tillie-Leblond I, Scheinmann P, Gosset P, de Blic J. Mast cells are associated with exacerbations and eosinophilia in children with severe asthma. Eur Respir J. 2016;48(5):1320–1328. doi:https://doi.org/10.1183/13993003.00947-2016.
   PubMed Web of Science ®Google Scholar
• Lezmi G, Gosset P, Deschildre A, Abou-Taam R, Mahut B, Beydon N, de Blic J. Airway Remodeling in Preschool Children with Severe Recurrent Wheeze. Am J Respir Crit Care Med. 2015;192(2):164–171. doi:https://doi.org/10.1164/rccm.201411-1958OC.
   PubMed Web of Science ®Google Scholar
• Dictionnaire Vidal, 2018. Available from: https://www.vidal.fr/.
   Google Scholar
• Liste des Produits et Prestations, l’Assurance Maladie 2018. Available from: https://www.ameli.fr/etablissement-de-sante/exercice-professionnel/nomenclatures-codage/lpp.
   Google Scholar
• Les règles de remboursement des consultations des médecins généralistes et spécialistes, L’Assurance Maladie Available from: https://www.ameli.fr/assure/remboursements/rembourse/consultations/metropole.
   Google Scholar
• La nomenclature générale des actes professionnels, l’Assurance Maladie. Available from: https://www.ameli.fr/infirmier/exercice-liberal/facturation-remuneration/nomenclatures-ngap-lpp/nomenclatures-ngap-lpp [updated 18 September 2017].
   Google Scholar
• Institut national de la statistique et des études économiques (INSEE) 2018. Available from: https://www.insee.fr/fr/statistiques/3204195.
   Google Scholar
• Godard P, Chanez P, Siraudin L, Nicoloyannis N, Duru G. Costs of asthma are correlated with severity: a 1-yr prospective study. Eur Respir J. 2002;19(1):61–67. doi:https://doi.org/10.1183/09031936.02.00232001.
   PubMed Web of Science ®Google Scholar
• Serra-Batlles J, Plaza V, Morejón E, Comella A, Brugués J. Costs of asthma according to the degree of severity. Eur Respir J. 1998;12(6):1322–1326. doi:https://doi.org/10.1183/09031936.98.12061322.
   PubMed Web of Science ®Google Scholar
• Van Ganse E, Antonicelli L, Zhang Q, Laforest L, Yin DD, Nocea G, Sazonov Kocevar V. Asthma-related resource use and cost by GINA classification of severity in three European countries. Respir Med. 2006;100(1):140–147. doi:https://doi.org/10.1016/j.rmed.2005.03.041.
   PubMed Web of Science ®Google Scholar
• Ferreira de Magalhães M, Amaral R, Pereira AM, Sá-Sousa A, Azevedo I, Azevedo LF, Fonseca JA. Cost of asthma in children: A nationwide, population-based, cost-of-illness study. Pediatr Allergy Immunol. 2017;28(7):683–691. doi:https://doi.org/10.1111/pai.12772.
   PubMed Web of Science ®Google Scholar
• Graf von der Schulenburg JM, Greiner W, Molitor S, Kielhorn A. [Cost of asthma therapy in relation to severity. An empirical study]. Med Klin (Munich). (Munich, Germany: 1983). 1996;91(10):670–676.
   PubMedGoogle Scholar
• Deschildre A, Marguet C, Salleron J, Pin I, Rittié J-L, Derelle J, Taam RA, Fayon M, Brouard J, Dubus JC, et al. Add-on omalizumab in children with severe allergic asthma: a 1-year real life survey. Eur Respir J. 2013;42(5):1224–1233. doi:https://doi.org/10.1183/09031936.00149812.
   PubMed Web of Science ®Google Scholar